DSpace at RU >

Browsing by Author Sutmuller, R.P.M.

Full Text	Issue Date	Title	Author(s)
	2004	CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.	Morgan, M.E.; Witteveen, H.J.; Sutmuller, R.P.M., et al
	2007	CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.	Grauer, O.M.; Nierkens, S.; Bennink, E.J., et al
	2004	Cellular membrane expression of heme oxygenase on dendritic cells; heme receptor or signaling mediator within the immunological synapse?	Wagener, F.A.D.T.G.; Broers, K.C.M.; Joosten, B.H.G.M., et al
	2010	Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.	Jacobs, J.F.M.; Punt, C.J.A.; Lesterhuis, W.J., et al
	2006	Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.	Brok, M.H.M.G.M. den; Sutmuller, R.P.M.; Nierkens, S., et al
	2008	Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.	Grauer, O.M.; Sutmuller, R.P.M.; Maren, W van, et al
	2005	From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.	Netea, M.G.; Meer, J.W.M. van der; Sutmuller, R.P.M., et al
	2004	In situ tumor ablation creates an antigen source for the generation of anti-tumor immunity	Brok, M.H.M.G.M. de; Sutmuller, R.P.M.; Voort, R. van der, et al
	2004	In situ tumor ablation creates an antigen source for the generation of antitumor immunity.	Brok, M.H.M.G.M. den; Sutmuller, R.P.M.; Voort, R. van der, et al
	2008	In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy.	Nierkens, S.; Brok, M.H.M.G.M. den; Sutmuller, R.P.M., et al
	2004	Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity.	Wansink, D.G.; Peters, W.J.M; Schaafsma, I., et al
	2011	Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation	Maren, W.W.C. van; Nierkens, S.; Toonen, L.W.J., et al
	2007	Regulatory T cells and toll-like receptors : regulating the regulators	Sutmuller, R.P.M.; Garritsen, A.; Adema, G.J.
	2004	Revival of the regulatory T cell: new targets for drug development.	Sutmuller, R.P.M.; Offringa, R.; Melief, C.J.
	2006	Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine	Ruers, T.J.M.; Brok, M. den; Sutmuller, R.P.M., et al
	2006	Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.	Brok, M.H.M.G.M. den; Sutmuller, R.P.M.; Nierkens, S., et al
	2008	TLR ligands in the local treatment of established intracerebral murine gliomas.	Grauer, O.M.; Molling, J.W.; Bennink, E., et al
	2006	Toll-like receptor 2 controls expansion and function of regulatory T cells.	Sutmuller, R.P.M.; Brok, M.H.M.G.M. den; Kramer, M., et al
	2004	Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.	Netea, M.G.; Sutmuller, R.P.M.; Hermann, C., et al
	2006	Toll-like receptors on regulatory T cells: expanding immune regulation.	Sutmuller, R.P.M.; Morgan, M.E.; Netea, M.G., et al